Search

Author/Creator Gerard, Perry

1. Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial. Issue 5 (18th May 2022)

Authors:
Hochberg, Jessica; Basso, Jaclyn; Shi, Qiuhu; Klejmont, Liana; Flower, Allyson; Bortfeld, Kristina; Harrison, Lauren; van de Ven, Carmella; Moorthy, Chitti; Islam, Humayun; Gerard, Perry; Voss, Stephan; Cairo, Mitchell S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 5(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Issue 1 (2nd January 2023)

Authors:
Gardenswartz, Aliza; Mehta, Brinda; El-Mallawany, Nader Kim; van de Ven, Carmella; Hochberg, Jessica; Flower, Allyson; Morris, Erin; Harrison, Lauren; Chu, Yaya; Basso, Jaclyn; Gerard, Perry; Islam, Humayun; Ayello, Janet; Baxter-Lowe, Lee Ann; Cairo, Mitchell S.
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 1(2023)
Page Start:
234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search